stockrow
Saturday 7 November 2026
Export REVB’s income statement to Excel — free account
Revelation Biosciences, Inc.
REVB Healthcare Biotechnology
- EPS
- +96.9%
- Free cash flow
- −35.3%
Quarter to June 2026, against a year earlier
3.70
0.14
+3.93%
Follow REVB
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
6.21 | 10.02 | 5.41 | 6.92 |
+8 more quarters Free account |
Net Debt/EBITDA |
3.14 | 4.57 | 4.17 | 6.56 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.77 | 0.37 | 0.78 | 0.34 | |
Capex/Depreciation |
(4.77) | (9.99) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(4.75) | (7.17) | (22.18) | (16.81) | |
Cash per Share |
20.98 | 30.79 | 120.63 | 134.48 | |
Shareholders Equity per Share |
18.40 | 28.34 | 99.90 | 116.42 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.40 | 28.34 | 99.90 | 116.42 | |
Free Cash Flow |
(2.60) | (3.29) | (1.97) | (1.59) | |
Working Capital |
9.80 | 12.79 | 8.81 | 10.98 | |
Capital Expenditures |
(0.04) | (0.07) | — | — | |
Net Current Asset Value |
9.25 | 12.15 | 8.09 | 10.98 | |
| Other line items | |||||
Quick Ratio |
6.11 | 9.96 | 5.36 | 6.85 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.67) | (7.01) | (22.18) | (16.81) | |
Capex per Share |
(0.07) | (0.16) | 0.00 | 0.00 | |
Average Payables |
0.88 | 0.73 | 0.68 | 2.08 | |
Average Assets |
8.95 | 9.51 | 9.10 | 9.80 | |
Average Common Equity |
6.95 | 7.93 | 6.78 | 6.84 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates · fundamentals updated 2 Nov 2026